-
21.发明授权公开(公告)号：US09168276B2
公开(公告)日：2015-10-27
申请号：US13878520
申请日：2011-10-05
IPC分类号： A61K36/45 , A61K36/28 , A61K36/185 , A61K36/00
CPC分类号： A61K36/00 , A61K36/185 , A61K36/28 , A61K36/45 , A61K2300/00
摘要： The present invention relates to formulations containing extracts of Vaccinium myrtillus or other species rich in anthocyanosides, Punica granatum, Echinacea, and optionally Krameria triandra. Said formulations are useful in the treatment of disorders of the mouth and its adnexa, the throat and respiratory tract, and in the treatment of influenza.
摘要翻译： 本发明涉及含有牛痘提取物或富含花色素苷的其他物种，扁桃属，松果菊，以及任选的克拉克氏菌（Krameria triandra）的制剂。 所述制剂可用于治疗口腔及其附件，咽喉和呼吸道疾病以及治疗流行性感冒。
-
22.再颁专利Hyperforin derivatives, the use thereof and formulations containing them 有权Hyperforin衍生物，其使用和含有它们的制剂公开(公告)号：USRE43280E1
公开(公告)日：2012-03-27
申请号：US12896158
申请日：2003-04-18
CPC分类号： C07C69/013 , C07C45/62 , C07C45/64 , C07C45/78 , C07C49/733 , C07C49/743 , C07C2602/46
摘要： The use of the reduction products of hyperforin and adhyperforin, pharmaceutically acceptable salts or esters thereof, in the pharmaceutical and/or nutritional field, in particular in the treatment of depression and Alzheimer's disease.
摘要翻译： 在制药和/或营养领域，特别是治疗抑郁症和阿尔茨海默氏病中，使用高效蛋白和高血压素的还原产物，其药学上可接受的盐或酯。
-
公开(公告)号：US07128932B2
公开(公告)日：2006-10-31
申请号：US10513730
申请日：2003-04-30
CPC分类号： A61K36/16 , A61K31/197 , A61K31/215 , A61K36/185 , A61K36/54 , A61K2300/00
摘要： Disclosed are pharmaceutical compositions containing: extracts of Tribulus terrestris, Turnera diffusa and Cinnamon cassia in the weight ratio of 1.5–3.5:1–2:0.1–0.4 respectively; Ginkgo biloba extract, and optionally arginine or a physiologically equivalent esters salts or precursor thereof. The compositions according to the invention are useful in the treatment of male and female sexual dysfunctions.
摘要翻译： 公开了药物组合物，其含量分别为：重量比为1.5-3.5：1-2：0.1-0.4的Trib藜提取物，Turnera diffusa和肉桂决明子; 银杏提取物，以及任选的精氨酸或其生理学上等同的酯盐或其前体。 根据本发明的组合物可用于治疗男性和女性性功能障碍。
-
24.发明授权Hyperforin derivatives, the use thereof and formulations containing them 有权Hyperforin衍生物，其使用和含有它们的制剂公开(公告)号：US07105705B2
公开(公告)日：2006-09-12
申请号：US10512067
申请日：2003-04-18
CPC分类号： C07C69/013 , C07C45/62 , C07C45/64 , C07C45/78 , C07C49/733 , C07C49/743 , C07C2602/46
摘要： The use of the reduction products of hyperforin and adhyperforin, pharmaceutically acceptable salts or esters thereof, in the pharmaceutical and/or nutritional field, in particular in the treatment of depression and Alzheimer's disease.
摘要翻译： 在制药和/或营养领域，特别是治疗抑郁症和阿尔茨海默氏病中，使用高效蛋白和高血压素，其药学上可接受的盐或酯的还原产物。
-
公开(公告)号：US07361370B2
公开(公告)日：2008-04-22
申请号：US10513819
申请日：2003-05-02
IPC分类号： A01N65/00
CPC分类号： A61K31/198 , A61K31/11 , A61K31/192 , A61K31/70 , A61K36/185 , A61K36/296 , A61K36/54 , A61K2300/00
摘要： Pharmaceutical compositions containing: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; and optionally arginine or a physiologically equivalent ester, salt or precursor thereof. The compositions are useful in the treatment of male and female sexual dysfunctions. A method of treatment using the pharmaceutical compositions is also described.
摘要翻译： 含有：枸杞提取物，韩文淫羊藿，肉桂桂的提取物，重量比分别为1.5-3.5：1-2：0.1-0.4; 和任选的精氨酸或其生理学上等同的酯，盐或其前体。 该组合物可用于治疗男性和女性性功能障碍。 还描述了使用药物组合物的治疗方法。
-
26.发明申请Hyperforin derivatives, the use thereof and formulations containing them 有权Hyperforin衍生物，其使用和含有它们的制剂公开(公告)号：US20050165117A1
公开(公告)日：2005-07-28
申请号：US10512067
申请日：2003-04-18
IPC分类号： A61P25/00 , A61K31/122 , A61P25/24 , A61P25/28 , C07C45/62 , C07C45/64 , C07C45/78 , C07C49/733 , C07C49/743 , C07C69/013 , C07C69/145 , C07C49/105 , A61K31/12 , A61K31/22
CPC分类号： C07C69/013 , C07C45/62 , C07C45/64 , C07C45/78 , C07C49/733 , C07C49/743 , C07C2602/46
摘要： The use of the reduction products of hyperforin and adhyperforin, pharmanceutically acceptable salts or esters thereof, in the pharmaceutical and/or nutritional field, ii particular in the treatment of depression and Alzheimer's disease.
摘要翻译： 在制药和/或营养领域中使用高效蛋白和高血压素，其药学上可接受的盐或酯的还原产物，特别是治疗抑郁症和阿尔茨海默氏病。
-
27.发明申请公开(公告)号：US20130280355A1
公开(公告)日：2013-10-24
申请号：US13878520
申请日：2011-10-05
CPC分类号： A61K36/00 , A61K36/185 , A61K36/28 , A61K36/45 , A61K2300/00
摘要： The present invention relates to formulations containing extracts of Vaccinium myrtillus or other species rich in anthocyanosides, Punica granatum, Echinacea, and optionally Krameria triandra. Said formulations are useful in the treatment of disorders of the mouth and its adnexa, the throat and respiratory tract, and in the treatment of influenza.
摘要翻译： 本发明涉及含有牛痘提取物或富含花色素苷的其他物种，扁桃属，松果菊，以及任选的克拉克氏菌（Krameria triandra）的制剂。 所述制剂可用于治疗口腔及其附件，咽喉和呼吸道疾病以及治疗流行性感冒。
-
公开(公告)号：US20130236575A1
公开(公告)日：2013-09-12
申请号：US13881412
申请日：2011-10-21
IPC分类号： A61K36/28 , A61K31/352 , A61K31/353
CPC分类号： A61K36/28 , A61K31/352 , A61K31/353 , A61K31/70 , A61K36/45 , A61K36/77 , A61K36/87 , A61K45/06 , A61K2300/00
摘要： The present invention relates to compositions containing a combination of a cell proliferation-stimulating agent with vasokinetic properties and an antimicrobial, antifungal and antiviral agent with an anti-inflammatory/analgesic, which is useful in the treatment of peripheral ulcers of various origins, such as diabetic ulcers, ulcers caused by venous stasis of the limbs, bedsores and the associated skin infections. Said combination could be presented as formulations for topical or systemic use.
摘要翻译： 本发明涉及包含具有血管动力学特性的细胞增殖刺激剂与具有抗炎/止痛剂的抗微生物，抗真菌和抗病毒剂的组合的组合物，其可用于治疗各种来源的外周溃疡，例如 糖尿病性溃疡，由四肢静脉淤滞，褥疮和相关皮肤感染引起的溃疡。 所述组合可以作为用于局部或全身使用的制剂来呈现。
-
29.发明授权Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity 有权用于治疗糖尿病和肥胖症的α-葡糖苷酶抑制剂的α-淀粉酶抑制剂的制剂公开(公告)号：US07553502B2
公开(公告)日：2009-06-30
申请号：US12042355
申请日：2008-03-05
IPC分类号： A01N65/00
CPC分类号： A61K36/37 , A61K36/48 , A61K2300/00
摘要： This invention relates to the combination of α-amylase inhibitors prepared from Phaseolus vulgaris with α-glucosidase inhibitors obtained from Salacia oblonga and other species. The α-amylase inhibitor is accompanied by a quantity of lectins that reduces the amount of glucose originating from the starches present in the diet, and considerably reduces the appetite after repeated administration. The combination with α-glucosidase inhibitors, such as extracts of Salacia or the thiosugars present in it, further reduce the blood glucose, acting synergically, and consequently reduce the synthesis of fats from carbohydrates.
摘要翻译： 本发明涉及从菜豆提取物制备的α-淀粉酶抑制剂与从长颈鹿藻和其他物种获得的α-葡糖苷酶抑制剂的组合。 α-淀粉酶抑制剂伴随着一定量的凝集素，其降低源自饮食中存在的淀粉的葡萄糖的量，并且在重复给药后显着降低食欲。 与α-葡萄糖苷酶抑制剂（如Salacia提取物或其中存在的硫代糖）的组合进一步降低血糖，协同作用，从而减少碳水化合物的脂肪合成。
-
30.发明申请FORMULATIONS OF ALPHA-AMYLASE INHIBITORS WITH ALPHA-GLUCOSIDASE INNHIBITORS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY 有权用于治疗糖尿病和肥胖症的ALPHA-葡萄糖苷酶抑制剂的阿尔法 - 淀粉酶抑制剂的配方公开(公告)号：US20080220098A1
公开(公告)日：2008-09-11
申请号：US12042355
申请日：2008-03-05
CPC分类号： A61K36/37 , A61K36/48 , A61K2300/00
摘要： This invention relates to the combination of α-amylase inhibitors prepared from Phaseolus vulgaris with α-glucosidase inhibitors obtained from Salacia oblonga and other species. The α-amylase inhibitor is accompanied by a quantity of lectins that reduces the amount of glucose originating from the starches present in the diet, and considerably reduces the appetite after repeated administration. The combination with α-glucosidase inhibitors, such as extracts of Salacia or the thiosugars present in it, further reduce the blood glucose, acting synergically, and consequently reduce the synthesis of fats from carbohydrates.
摘要翻译： 本发明涉及从菜豆提取物制备的α-淀粉酶抑制剂与从长颈鹿藻和其他物种获得的α-葡糖苷酶抑制剂的组合。 α-淀粉酶抑制剂伴随着一定量的凝集素，其降低源自饮食中存在的淀粉的葡萄糖的量，并且在重复给药后显着降低食欲。 与α-葡萄糖苷酶抑制剂（如Salacia提取物或其中存在的硫代糖）的组合进一步降低血糖，协同作用，从而减少碳水化合物的脂肪合成。
-
-
-
-
-
-
-
-
-
搜索结果
76 条记录 (耗时 0.029 秒)
